Stevanato Group S.p.A (STVN) Asset Writedowns and Impairment (2020 - 2026)
Stevanato Group S.p.A (STVN) posted quarterly Asset Writedowns and Impairment of -$151026.2 for Q1 2026, up 63.37% year-over-year from -$92442.4 in Q1 2025, and down 127.78% quarter-over-quarter from $543610.6 in Q3 2025.
Stevanato Group S.p.A (STVN) Asset Writedowns and Impairment (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has reported Asset Writedowns and Impairment for 7 consecutive years, with -$151026.2 the latest figure, recorded in Q1 2026.
- In Q1 2026, Asset Writedowns and Impairment rose 63.37% year-over-year to -$151026.2; the TTM figure through Mar 2026 stood at $103629.3 (up 186.87% YoY), while the FY2021 annual figure was -$1.5 million, down 475.77% from the prior year.
- Asset Writedowns and Impairment eased to -$151026.2 in Q1 2026 per STVN's latest filing, from $543610.6 in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $746939.7 in Q2 2022 and bottomed at -$412338.7 in Q1 2025.
- Historically, Asset Writedowns and Impairment has averaged $72880.2 across 5 years, with a median of -$59303.9 in 2024.
- Annual changes were most pronounced in 2024 — Asset Writedowns and Impairment sank 492.82% — and 2025, when it soared 1016.65%.
- Stevanato Group S.p.A's Asset Writedowns and Impairment stood at -$80661.9 in 2022, then slumped by 364.25% to -$374475.1 in 2023, then soared by 84.16% to -$59303.9 in 2024, then jumped by 1016.65% to $543610.6 in 2025, then sank by 127.78% to -$151026.2 in 2026.
- Business Quant data shows STVN's Asset Writedowns and Impairment at -$151026.2 in Q1 2026, $543610.6 in Q3 2025, and $123383.6 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Stevanato Group S.p.A | 6.18 Bn | 6.07 Bn | 100.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 282,453.93 |
| Jun 30, 2026 | 282,453.93 |
| Mar 31, 2026 | -151,026.19 |
| Mar 31, 2026 | -151,026.19 |
| Sep 30, 2025 | 543,610.62 |
| Sep 30, 2025 | 543,610.62 |
| Jun 30, 2025 | 123,383.61 |
| Jun 30, 2025 | 123,383.61 |
| Mar 31, 2025 | -412,338.70 |
| Mar 31, 2025 | -412,338.70 |
| Sep 30, 2024 | -59,303.85 |
| Sep 30, 2024 | -59,303.85 |
| Jun 30, 2024 | 575,057.97 |
| Jun 30, 2024 | 575,057.97 |
| Mar 31, 2024 | -222,704.16 |
| Mar 31, 2024 | -222,704.16 |
| Sep 30, 2023 | -374,475.12 |
| Sep 30, 2023 | -374,475.12 |
| Jun 30, 2023 | 358,256.12 |
| Jun 30, 2023 | 358,256.12 |